v3.24.1.1.u2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net loss $ (1,903,794) $ (1,325,547)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 431 431
Stock-based compensation 335,417 127,450
Shares issued for services 50,000
Loss on conversion of notes 92,959
Changes in operating assets and liabilities:    
Prepaid expense (486,714) (791,298)
Accounts payable 50,886 92,898
Accrued expenses 102,140 (608,229)
Net cash used in operating activities (1,901,634) (2,361,336)
Cash flows from investing activities:    
Purchases of property and equipment
Net cash used in investing activities
Cash flows from financing activities:    
Proceeds from issuance of common stock and warrants, net of issuance costs 5,674,651 7,293,651
Proceeds from warrant exercises 105,816
Proceeds from notes payable 100,000
Payments of notes payable (299,950)
Proceeds from short term insurance financing 561,885 697,534
Payments of short term insurance financing (54,731) (68,048)
Net cash provided by financing activities 6,287,621 7,723,187
Net increase in cash and cash equivalents 4,385,987 5,361,851
Cash and cash equivalents, beginning of period 2,624,730 57,670
Cash and cash equivalents, end of period 7,010,717 5,419,521
Supplemental cash flow information:    
Cash paid for interest 3,273 83,074
Cash paid for taxes
Supplemental non-cash activity    
Issuance of common stock upon conversion of notes payable $ 1,535,615

Source

HTML PDF
ZIP